Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 3 10Phase 1 5Phase NA 2Phase 2/3 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 48INDUSTRY 2NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 169Neoplasms 128Prostatic Neoplasms 92Lung Neoplasms 82Colorectal Neoplasms 80Pancreatic Neoplasms 38Leiomyoma 37Carcinoma, Hepatocellular 36Lymphoma, Follicular 35Carcinoma, Non-Small-Cell Lung 30Neoplasm Metastasis 27Skin Neoplasms 26Colonic Neoplasms 26Uterine Cervical Neoplasms 25Liver Neoplasms 25Multiple Myeloma 23Glioblastoma 22Head and Neck Neoplasms 21Barrett Esophagus 21Polycystic Ovary Syndrome 19Brain Neoplasms 18Urinary Bladder Neoplasms 17Polyps 16Ovarian Neoplasms 15Esophageal Neoplasms 15Stomach Neoplasms 14Squamous Cell Carcinoma of Head and Neck 14Rectal Neoplasms 14Carcinoma, Squamous Cell 14Carcinoma, Basal Cell 14

Interventions

Food 1Dietary Supplements 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Cachexia × Clear all
NCT02515032 2017-07-17

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia

Smartfish AS

Phase NA Completed
56 enrolled

Cachexia

NCT00851448 2011-06-02

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients

Fresenius Kabi

Phase NA Terminated
17 enrolled

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡